Wednesday, February 10, 2010, 3:57pm SGT - The Singapore stock market closes in 1 hour and 3 minutes.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEINVESTINGFINANCE NEWS
    Market:       |  

OccuLogix Inc. (TEAR)

At 3:42AM SGT: 1.03 USD  Down 0.03 (2.83%)  
 MORE ON TEAR 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 OccuLogix, Inc. (NCM:TEAR) Delayed quote dataEdit
Last Trade:1.03 USD
Trade Time:3:42AM SGT
Change:Down 0.03 (2.83%)
Prev Close:1.06
Open:1.15
Bid:0.88 x 500
Ask:N/A
1y Target Est:1.00
Day's Range:1.03 - 1.15
52wk Range:0.70 - 3.60
Volume:600
Avg Vol (3m):4,939.68
Market Cap:10.16M
P/E (ttm):N/A
EPS (ttm):-1.00
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
Use Y! Toolbar to track stocks
 Add TEAR to Portfolio   Download Data

 HEADLINES 
•OCCULOGIX, INC. Files SEC form 8-K/A, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
EDGAR Online (Tue, Jan 12)
•OCCULOGIX, INC. Files SEC form 8-K, Unregistered Sale of Equity Securities, Financial Statements and Exhibits
EDGAR Online (Tue, Jan 12)
•OccuLogix (dba TearLab Corporation) Announces Total Equity Raise of $3,000,000
GlobeNewswire (Tue, Jan 12)
•TearLab Achieves Health Canada Approval
GlobeNewswire (Wed, Dec 9)
•OCCULOGIX, INC. Financials
EDGAR Online Financials (Fri, Nov 20)
•OCCULOGIX, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
EDGAR Online (Tue, Nov 17)
•OCCULOGIX, INC. Files SEC form 10-Q, Quarterly Report
EDGAR Online (Sat, Nov 14)
•OccuLogix, dba TearLab Corporation, Reports Q3-09 Financial Results
GlobeNewswire (Fri, Nov 13)
•Q3 2009 OccuLogix, Inc. Earnings Release - After Market Close
CCBN (Thu, Nov 12)
•TearLab Corporation to Release Q3-09 Financial Results on November 12 -- Conference Call to Follow
GlobeNewswire (Thu, Nov 5)
More Headlines for TEAR...
 ANALYST 
EPS Est (next year) (Dec-09) :N/A
EPS Est (in 2 years) (Dec-10) :N/A
Avg Rec (current)*:2.0
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
OccuLogix, Inc., an ophthalmic device company, engages in commercializing a proprietary in vitro diagnostic tear testing platform, the TearLab test for dry eye disease.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
•Latest News•Singapore Indices